Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Botanix Pharmaceuticals.
RELATED STOCKHEAD STORIES
Health & Biotech
As it awaits crucial FDA approval Botanix reckons Aussies have a penchant for backing high-risk companies
Health & Biotech
Check Up: Almost half a billion US dollars raised to bring back mammoth, dodo, and Tassie tiger
Experts
SUNDAY ROAST: The small caps that lit a fire under Stockhead’s experts this week
Experts
This broker says Botanix Pharma’s share price could more than triple on an FDA approval
Experts
Tim Boreham’s 20 ASX stocks that are primed to run in 2023 – Part 2
Health & Biotech
Weed Week: More US states vote to legalise cannabis and Czech Republic to follow in Germany’s footsteps
Health & Biotech
ASX Biotech Stocks: Nuheara secures historic FDA clearance for its over-the-counter hearing aid
Explainers
ASX Cannabis Stocks Guide 2022/23: Here’s everything you need to know
News
LAST ORDERS: A whimsical look at what you might have missed today
Health & Biotech
ASX Health Stocks: Botanix seeks nod from US FDA; PainChek goes big in Japan
Health & Biotech
ASX Health Stocks: FDA to expedite submission for Botanix’s sweaty armpits gel
Health & Biotech
Cast your eyes over these 15 weird and wonderful biotech stocks we found on the ASX
Health & Biotech
ScoPo’s Powerplays: Health stocks tumble but half-price sale presents buying opportunities
Health & Biotech
Weed Week: Jim Belushi headlines cannabis expo and the first legal seedbank established in Denmark
News
Market Highlights and 5 ASX Small Caps to watch on Thursday
Stockhead TV
Resolving Acne: Dermatology innovations in biotech
News